[
  {
    "ts": "2026-02-04T03:18:28+00:00",
    "headline": "Merck Deepens Oncology And Vaccine Bets With Partnerships And Equity Stake",
    "summary": "Merck (NYSE:MRK) has taken a significant equity stake in Eikon Therapeutics, expanding its presence in oncology-focused biotech. The company has entered a global oncology collaboration with Guardant Health to advance cancer diagnostics and treatment approaches. Merck is also leading efforts to improve global access to vaccines targeting Zaire ebolavirus, aiming to broaden distribution and use. For you as an investor, these moves sit squarely within Merck's core areas in cancer and vaccines,...",
    "url": "https://finance.yahoo.com/news/merck-deepens-oncology-vaccine-bets-031828719.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "01ae13a9-a70e-3609-9a7c-b5e0b02a120d",
      "content": {
        "id": "01ae13a9-a70e-3609-9a7c-b5e0b02a120d",
        "contentType": "STORY",
        "title": "Merck Deepens Oncology And Vaccine Bets With Partnerships And Equity Stake",
        "description": "",
        "summary": "Merck (NYSE:MRK) has taken a significant equity stake in Eikon Therapeutics, expanding its presence in oncology-focused biotech. The company has entered a global oncology collaboration with Guardant Health to advance cancer diagnostics and treatment approaches. Merck is also leading efforts to improve global access to vaccines targeting Zaire ebolavirus, aiming to broaden distribution and use. For you as an investor, these moves sit squarely within Merck's core areas in cancer and vaccines,...",
        "pubDate": "2026-02-04T03:18:28Z",
        "displayTime": "2026-02-04T03:18:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kA84g.s9IO2ClCgTX6BCgg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DmY770n7xz5DXLM6ZHLmxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-deepens-oncology-vaccine-bets-031828719.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-deepens-oncology-vaccine-bets-031828719.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T06:08:04+00:00",
    "headline": "Merck & Co., Inc. Q4 Earnings Call Highlights",
    "summary": "Merck & Co., Inc. (NYSE:MRK) reported fourth-quarter 2025 revenue of $16.4 billion, up 5% year over year (4% excluding foreign exchange), as continued growth in oncology and animal health helped offset a sharp decline in Gardasil sales driven by weaker demand in China and Japan. Management also",
    "url": "https://www.marketbeat.com/instant-alerts/merck-co-inc-q4-earnings-call-highlights-2026-02-04/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "339052be-59d3-3370-8c6a-b77ed4d3df42",
      "content": {
        "id": "339052be-59d3-3370-8c6a-b77ed4d3df42",
        "contentType": "STORY",
        "title": "Merck & Co., Inc. Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) reported fourth-quarter 2025 revenue of $16.4 billion, up 5% year over year (4% excluding foreign exchange), as continued growth in oncology and animal health helped offset a sharp decline in Gardasil sales driven by weaker demand in China and Japan. Management also",
        "pubDate": "2026-02-04T06:08:04Z",
        "displayTime": "2026-02-04T06:08:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/e23c38395a2f6cd099d4d7f775327c97",
          "originalWidth": 1200,
          "originalHeight": 1200,
          "caption": "Merck & Co., Inc. logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RoLR8pS2jP_VNEZ6RQ6nYg--~B/aD0xMjAwO3c9MTIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/marketbeat_955/e23c38395a2f6cd099d4d7f775327c97.cf.webp",
              "width": 1200,
              "height": 1200,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PP8McusDEbIaqCDbJ_Ua2A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/e23c38395a2f6cd099d4d7f775327c97.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/merck-co-inc-q4-earnings-call-highlights-2026-02-04/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-inc-q4-earnings-060804398.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]